TGF-β1 could be a missing link in the interplay between ER and HER-2 in breast cancer
- 31 December 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 65 (3) , 546-551
- https://doi.org/10.1016/j.mehy.2005.03.019
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prognostic value of proliferation in invasive breast cancer: a reviewJournal of Clinical Pathology, 2004
- Cytostatic and apoptotic actions of TGF-β in homeostasis and cancerNature Reviews Cancer, 2003
- Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progressionEuropean Journal Of Cancer, 2003
- Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastasesJournal of Clinical Investigation, 2002
- Histological and biological evolution of human premalignant breast disease.Endocrine-Related Cancer, 2001
- Individual characterisation of the metastatic capacity of human breast carcinomaEuropean Journal Of Cancer, 2000
- Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-βBreast Cancer Research, 2000
- Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.Endocrine-Related Cancer, 1999
- Steroid hormone receptors in breast cancer managementBreast Cancer Research and Treatment, 1998
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987